Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research

Abstract Background Human induced pluripotent stem (iPS) cell-derived enterocyte-like cells (ELCs) are expected to be useful for evaluating the intestinal absorption and metabolism of orally administered drugs. However, it is difficult to generate large amounts of ELCs with high quality because they...

Full description

Bibliographic Details
Main Authors: Tatsuya Inui, Yusei Uraya, Jumpei Yokota, Tomoki Yamashita, Kanae Kawai, Kentaro Okada, Yukiko Ueyama-Toba, Hiroyuki Mizuguchi
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-03685-5
_version_ 1797275594188128256
author Tatsuya Inui
Yusei Uraya
Jumpei Yokota
Tomoki Yamashita
Kanae Kawai
Kentaro Okada
Yukiko Ueyama-Toba
Hiroyuki Mizuguchi
author_facet Tatsuya Inui
Yusei Uraya
Jumpei Yokota
Tomoki Yamashita
Kanae Kawai
Kentaro Okada
Yukiko Ueyama-Toba
Hiroyuki Mizuguchi
author_sort Tatsuya Inui
collection DOAJ
description Abstract Background Human induced pluripotent stem (iPS) cell-derived enterocyte-like cells (ELCs) are expected to be useful for evaluating the intestinal absorption and metabolism of orally administered drugs. However, it is difficult to generate large amounts of ELCs with high quality because they cannot proliferate and be passaged. Methods To solve the issue above, we have established intestinal organoids from ELCs generated using our protocol. Furthermore, monolayers were produced from the organoids. We evaluated the usefulness of the monolayers by comparing their functions with those of the original ELCs and the organoids. Results We established organoids from ELCs (ELC-org) that could be passaged and maintained for more than a year. When ELC-org were dissociated into single cells and seeded on cell culture inserts (ELC-org-mono), they formed a tight monolayer in 3 days. Both ELC-org and ELC-org-mono were composed exclusively of epithelial cells. Gene expressions of many drug-metabolizing enzymes and drug transporters in ELC-org-mono were enhanced, as compared with those in ELC-org, to a level comparable to those in adult human small intestine. The CYP3A4 activity level in ELC-org-mono was comparable or higher than that in primary cryopreserved human small intestinal cells. ELC-org-mono had the efflux activities of P-gp and BCRP. Importantly, ELC-org-mono maintained high intestinal functions without any negative effects even after long-term culture (for more than a year) or cryopreservation. RNA-seq analysis showed that ELC-org-mono were more mature as intestinal epithelial cells than ELCs or ELC-org. Conclusions We have successfully improved the function and convenience of ELCs by utilizing organoid technology.
first_indexed 2024-03-07T15:16:42Z
format Article
id doaj.art-0d9f9919464a474da5281380fc90759e
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-03-07T15:16:42Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-0d9f9919464a474da5281380fc90759e2024-03-05T17:52:12ZengBMCStem Cell Research & Therapy1757-65122024-02-0115111510.1186/s13287-024-03685-5Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery researchTatsuya Inui0Yusei Uraya1Jumpei Yokota2Tomoki Yamashita3Kanae Kawai4Kentaro Okada5Yukiko Ueyama-Toba6Hiroyuki Mizuguchi7Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityLaboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka UniversityAbstract Background Human induced pluripotent stem (iPS) cell-derived enterocyte-like cells (ELCs) are expected to be useful for evaluating the intestinal absorption and metabolism of orally administered drugs. However, it is difficult to generate large amounts of ELCs with high quality because they cannot proliferate and be passaged. Methods To solve the issue above, we have established intestinal organoids from ELCs generated using our protocol. Furthermore, monolayers were produced from the organoids. We evaluated the usefulness of the monolayers by comparing their functions with those of the original ELCs and the organoids. Results We established organoids from ELCs (ELC-org) that could be passaged and maintained for more than a year. When ELC-org were dissociated into single cells and seeded on cell culture inserts (ELC-org-mono), they formed a tight monolayer in 3 days. Both ELC-org and ELC-org-mono were composed exclusively of epithelial cells. Gene expressions of many drug-metabolizing enzymes and drug transporters in ELC-org-mono were enhanced, as compared with those in ELC-org, to a level comparable to those in adult human small intestine. The CYP3A4 activity level in ELC-org-mono was comparable or higher than that in primary cryopreserved human small intestinal cells. ELC-org-mono had the efflux activities of P-gp and BCRP. Importantly, ELC-org-mono maintained high intestinal functions without any negative effects even after long-term culture (for more than a year) or cryopreservation. RNA-seq analysis showed that ELC-org-mono were more mature as intestinal epithelial cells than ELCs or ELC-org. Conclusions We have successfully improved the function and convenience of ELCs by utilizing organoid technology.https://doi.org/10.1186/s13287-024-03685-5Intestinal organoidsSmall intestineiPS cellDrug-metabolizing enzymesDrug transporters
spellingShingle Tatsuya Inui
Yusei Uraya
Jumpei Yokota
Tomoki Yamashita
Kanae Kawai
Kentaro Okada
Yukiko Ueyama-Toba
Hiroyuki Mizuguchi
Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
Stem Cell Research & Therapy
Intestinal organoids
Small intestine
iPS cell
Drug-metabolizing enzymes
Drug transporters
title Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
title_full Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
title_fullStr Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
title_full_unstemmed Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
title_short Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research
title_sort functional intestinal monolayers from organoids derived from human ips cells for drug discovery research
topic Intestinal organoids
Small intestine
iPS cell
Drug-metabolizing enzymes
Drug transporters
url https://doi.org/10.1186/s13287-024-03685-5
work_keys_str_mv AT tatsuyainui functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT yuseiuraya functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT jumpeiyokota functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT tomokiyamashita functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT kanaekawai functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT kentarookada functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT yukikoueyamatoba functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch
AT hiroyukimizuguchi functionalintestinalmonolayersfromorganoidsderivedfromhumanipscellsfordrugdiscoveryresearch